BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28916967)

  • 1. Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.
    Miyatani K; Saito H; Kono Y; Murakami Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    Surg Today; 2018 Mar; 48(3):300-307. PubMed ID: 28916967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
    Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
    Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Relevance of Postoperative Neutrophil-Lymphocyte Ratio (NLR) to Recurrence After Adjuvant Chemotherapy of S-1 for Gastric Cancer.
    Tanaka H; Tamura T; Toyokawa T; Muguruma K; Miki Y; Kubo N; Sakurai K; Hirakawa K; Ohira M
    Anticancer Res; 2018 Jun; 38(6):3745-3751. PubMed ID: 29848737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China.
    Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP
    Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.
    Pang W; Lou N; Jin C; Hu C; Arvine C; Zhu G; Shen X
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):493-502. PubMed ID: 26854795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.
    Wang SC; Chou JF; Strong VE; Brennan MF; Capanu M; Coit DG
    Ann Surg; 2016 Feb; 263(2):292-7. PubMed ID: 25915915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
    Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
    Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
    Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative neutrophil-to-lymphocyte ratio behaves as an independent prognostic factor even in patients with postoperative complications after curative resection for gastric cancer.
    Tur-Martínez J; Osorio J; Pérez-Romero N; Puértolas-Rico N; Pera M; Delgado S; Rodríguez-Santiago J
    Langenbecks Arch Surg; 2022 May; 407(3):1017-1026. PubMed ID: 34999967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
    Murakami Y; Saito H; Shimizu S; Kono Y; Shishido Y; Miyatani K; Matsunaga T; Fukumoto Y; Fujiwara Y
    Anticancer Res; 2019 May; 39(5):2583-2589. PubMed ID: 31092456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preoperative and the postoperative neutrophil-to-lymphocyte ratios both predict prognosis in gastric cancer patients.
    Kim EY; Song KY
    World J Surg Oncol; 2020 Nov; 18(1):293. PubMed ID: 33172490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
    Yu L; Lv CY; Yuan AH; Chen W; Wu AW
    World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence.
    Jiang Y; Xu H; Jiang H; Ding S; Zheng T
    Cancer Biomark; 2016 Mar; 16(4):523-8. PubMed ID: 27062567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer: A Single Institutional Cohort Study.
    Mohri Y; Tanaka K; Toiyama Y; Ohi M; Yasuda H; Inoue Y; Kusunoki M
    Medicine (Baltimore); 2016 Mar; 95(11):e3125. PubMed ID: 26986164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of inflammation-based markers in patients with recurrent gastric cancer.
    Migita K; Matsumoto S; Wakatsuki K; Ito M; Kunishige T; Nakade H; Kitano M; Nakatani M; Sho M
    Surg Today; 2018 Mar; 48(3):282-291. PubMed ID: 28836056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.